Search
for
Sort by
Research 181–210 of 1000+
- Polycystic ovary syndrome is associated with atherogenic changes in lipoprotein particle number and size independent of body weight
- Revisiting hyper- and hypo-androgenism by tandem mass spectrometry
- Chromium supplementation in women with polycystic ovary syndrome: Systematic review and meta-analysis
- Clinical and metabolic implications of obesity in prostate cancer: is testosterone a missing link?
- Anti-Müllerian hormone gene polymorphism is associated with androgen levels in Chinese polycystic ovary syndrome patients with insulin resistance
- Spironolactone May be a Cause of Hormonally Associated Vestibulodynia and Female Sexual Arousal Disorder
- Androgens in Women – Critical Evaluation of the Methods for Their Determination in Diagnostics of Endocrine Disorders
- The differences between aromatizable and non-aromatizable androgens in relation to body composition and metabolic syndrome risk factors in men
- Variations in alanine aminotransferase levels within the normal range predict metabolic and androgenic phenotypes in women of reproductive age
- Evaluation of serum level of omentin‐1 in females with hirsutism
- Association of ACE2, Insulin Resistance, and Other Parameters in Obese Polycystic Ovary Syndrome Patients Infected with COVID-19
- Effects of 5-alpha reductase inhibitors
- Diagnosing polycystic ovary syndrome
- A Case of Hidradenitis Suppurativa Responsive to Testosterone Replacement Therapy
- Associations between genetically predicted sex and growth hormones and facial aging in the UK Biobank: a two−sample Mendelian randomization study
- Clinical Utility of GnRH Analogues in Female Androgen Excess: Highlighting Diagnostic and Therapeutic Applications
- Comparison of metformin and N-acetylcysteine on metabolic parameters in women with polycystic ovarian syndrome
- HORMONAL STATUS IN POSTMENOPAUSAL ANDROGENETIC ALOPECIA
- The Predictive Value of Clinical Hirsutism for Biochemical Hyperandrogenism in a Large Endocrine Referral Cohort
- Evaluation of dihydrotestosterone levels and total testosterone to dihydrotestosterone ratio with clinical symptoms and metabolic parameters in patients with polycystic ovary syndrome
- Altered Hormone and Bioactive Lipid Plasma Profile in Rodent Models of Polycystic Ovarian Syndrome Revealed by Targeted Mass Spectrometry
- The Effects of Single Testosterone Administration and Stress Induction on Steroid Hormone Levels in Hair
- Efficacy and safety of systemic spironolactone for acne in female patients in Sulaymaniyah teaching center of dermatology
- Effect of Exercise Interventions on Metabolic, Reproductive and Mental Health in Overweight Women with Polycystic Ovary Syndrome
- SUN-195 Falsely Elevated Testosterone Levels: Role of LC-MS/MS in Reducing Unnecessary Testing
- Evaluation of the role of soluble receptors for advanced glycosylated end-products in polycystic ovarian syndrome
- Botanical Treatment for Polycystic Ovary Syndrome
- Hyperandrogenemia in an ethnically heterogeneous cohort of Midwestern United States diabetic gestations
- USE OF SPIRONOLACTONE IN COMBINATION WITH AN ORAL CONTRACEPTIVE IN TREATMENT OF HIRSUTISM
- Urinary steroids in women with androgenic alopecia